38 unknown. 38 Phase 1, 27 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 38 | Unknown 38 |
| Phase 2 | 27 | Unknown 27 |
Follow Inflammation: new trials by email Literature Review of Inflammation trials Research Report on Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Undergoing On-pump CABG Normal saline, Dexmedetomidine, Methylprednisolone - Coronary Artery Disease, Systemic Inflammatory Response Syndrome | Phase 1 / Phase 2 | Unknown | Ain Shams University | 60 | 2025-09-01 | 2025-08-06 |
| Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis Imatinib, Compound sodium lactate solution - Sepsis, Fluid Overload | Phase 1 / Phase 2 | Unknown | Belfast Health and Social Care Trust | 65 | 2024-12-01 | 2024-10-04 |
| Beta-Hydroxybutyrate Feasibility Treating IBD Feasibility of beta-hydroxybutyrate supplementation to reduce inflammation in patients with Crohn's - Crohn's Disease, Inflammatory Bowel Diseases | Phase 1 / Phase 2 | Unknown | University of Texas at Austin | 20 | 2024-08-28 | 2024-09-19 |
| Effect of Quercetin in Treatment of Periodontitis Quercetin, scaling and root planing - Inflammation Gum | Phase 1 | Unknown | Assiut University | 20 | 2024-02-20 | 2024-01-31 |
| Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air 0.070 ppm ozone concentration, Clean air (0.0 ppm ozone) - Lung Injury, Acute, Symptoms and Signs | Phase 1 | Unknown | Martin W. Case | 60 | 2022-10-13 | 2023-01-11 |
| KurCoSmart Effects on People With Type 2 DM Curcumin and virgin coconut oil extract (KurCo Smart) - Diabetes Mellitus, Type 2, Insulin Resistance | Phase 1 / Phase 2 | Unknown | Universitas Sebelas Maret | 40 | 2022-06-01 | 2022-06-07 |
| The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock Ondansetron, Placebo - Sepsis, Septic Shock | Phase 1 / Phase 2 | Unknown | Noha Mansour | 40 | 2022-04-24 | 2023-03-15 |
| Study for the Prevention of Oral Mucositis (SPOM) Bocaliner, Benzydamine - Oral Mucositis | Phase 1 / Phase 2 | Unknown | E2Bio Life Sciences, LLC | 100 | 2022-04-15 | 2023-09-08 |
| Colchicine Effect on Perivascular Inflammation Index on Coronary CTA Colchicine - Atherosclerosis, Inflammatory Response | Phase 1 | Unknown | University of Sao Paulo General Hospital | 40 | 2022-03-07 | 2022-05-09 |
| Anakinra for Preterm Infants Pilot Anakinra - Prematurity; Extreme, Inflammation | Phase 1 / Phase 2 | Unknown | Monash Medical Centre | 25 | 2022-02-15 | 2024-09-19 |
| Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic Patients Albumin 20% and terlipressin - Septic Shock | Phase 1 | Unknown | Amany Mousa Salama Muhammed | 36 | 2021-10-01 | 2021-10-15 |
| High-dose Intravenous Vitamin C in Patients With Septic Shock Sodium Ascorbate - Sepsis, Severe, Septic Shock | Phase 1 | Unknown | Melbourne Health | 30 | 2021-09-27 | 2022-11-04 |
| A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy SBI-101 - COVID-19, Acute Kidney Injury | Phase 1 / Phase 2 | Unknown | Sentien Biotechnologies, Inc. | 22 | 2020-11-19 | 2022-01-14 |
| Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19) Methotrexate-LDE phase 1, Methotrexate-LDE phase 2, Placebo-LDE phase 2 - Coronavirus, Inflammation | Phase 1 / Phase 2 | Unknown | University of Sao Paulo General Hospital | 100 | 2020-10-27 | 2021-01-14 |
| Fighting Immunosenescence and Promoting Immunity by a Fasting-mimicking Diet Elderly. Prolon - FMD - Frailty, Inflammation | Phase 1 / Phase 2 | Unknown | University of Genova | 40 | 2020-09-15 | 2021-10-25 |
| Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831 Drug: NA-831 - 0.10 mg/kg, Placebo- 0.10 mg/kg, Drug: NA-831 - 0.20 mg/kg - Covid19, Corona Virus Infection | Phase 1 | Unknown | Biomed Industries, Inc. | 45 | 2020-09-15 | 2020-07-21 |
| Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients Collagen-Polyvinylpyrrolidone - Covid19, Cytokine Storm | Phase 1 / Phase 2 | Unknown | Janette Furuzawa Carballeda | 90 | 2020-08-19 | 2021-02-17 |
| LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab - COVID-19, Hospitalized COVID-19 Patients | Phase 1 | Unknown | Lebanese University | 1000 | 2020-03-28 | 2024-02-06 |
| Biological Effects of Quercetin in COPD Quercetin - Chronic Obstructive Pulmonary Disease | Phase 1 / Phase 2 | Unknown | Temple University | 29 | 2019-10-01 | 2023-08-16 |
| Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells Metoprolol, metoprolol, infliximab, etanercept, tocilizumab and/or other agents - Solid Tumor, Hematological Malignancy | Phase 1 / Phase 2 | Unknown | Chinese PLA General Hospital | 30 | 2019-09-15 | 2022-04-13 |
Showing 20 of 38. Sign in to see all of them.
Sepsis (6) · COVID-19 (5) · Shock, Septic (4) · Atherosclerosis (3) · Acute Lung Injury (2) · Carcinoma, Hepatocellular (2) · Coronavirus Infections (2) · Crohn Disease (2) · Cytokine Release Syndrome (2) · Diabetes Mellitus, Type 2 (2) · Immune System Diseases (2) · Insulin Resistance (2) · Psychotic Disorders (2) · Schizophrenia (2)
Pathologic Processes (38) · Pathological Conditions, Signs and Symptoms (38) · Infections (13) · Lung Diseases (12) · Respiratory Tract Diseases (12) · Systemic Inflammatory Response Syndrome (10) · Shock (8) · Digestive System Diseases (6) · Coronaviridae Infections (5) · Nidovirales Infections (5) · Pneumonia, Viral (5) · RNA Virus Infections (5) · Respiratory Tract Infections (5) · Signs and Symptoms (5)
Saline Solution (3) · Quercetin (2) · remdesivir (2) · tocilizumab (2) · Albumins (1) · Anti-Inflammatory Agents (1) · Antiretroviral Therapy, Highly Active (1) · Ascorbic Acid (1) · Benzydamine (1) · Budesonide (1) · CHR 2845 (1) · Cilastatin, Imipenem Drug Combination (1) · Citrulline (1) · Colchicine (1) · Control Groups (1)
Ain Shams University (2) · Brian Miller (2) · Fast Forward Pharmaceuticals (2) · Lebanese University (2) · University of Sao Paulo General Hospital (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Amany Mousa Salama Muhammed (1) · Assiut University (1) · Belfast Health and Social Care Trust (1) · Biomed Industries, Inc. (1) · Chinese PLA General Hospital (1) · E2Bio Life Sciences, LLC (1) · Instituto Mexicano del Seguro Social (1) · Janette Furuzawa Carballeda (1) · Karolinska Institutet (1)
United States (8) · China (4) · Egypt (3) · Netherlands (3) · Australia (2) · Brazil (2) · Lebanon (2) · Mexico (2) · United Kingdom (2) · Armenia (1) · Belgium (1) · Canada (1) · Indonesia (1) · Italy (1) · New Zealand (1)
Nehman Makdissy, Professor (2) · Ahmed Mortada Fikry, professor (1) · Andy Ghio, M.D. (1) · Brian J Miller, MD (1) · Claudia Nold, Prof (1) · Daniel Azamar-Llamas, MD (1) · David Propper (1) · Eduardo Almeida Gutierrez, MSc (1) · Eric Ochoa-Hein, MD (1) · Erik S Stroes, MD PhD (1)
PMID 10415784, PMID 12563677, PMID 14719037, PMID 15663512, PMID 16164444, PMID 17181919, PMID 17662768, PMID 18097874, PMID 19056593, PMID 19105791, PMID 19397687, PMID 19453649, PMID 19998041, PMID 20084502, PMID 20920189, PMID 21131395, PMID 22028728, PMID 22465313, PMID 22545014, PMID 22666356, PMID 22731679, PMID 23327349, PMID 23509945, PMID 23612995, PMID 23782971, PMID 26867177, PMID 28584818, PMID 29975735, PMID 30473697, PMID 31986264, PMID 32007143, PMID 32035018, PMID 32089354, PMID 32113509, PMID 32122636, PMID 32125455, PMID 32159775, PMID 32192578, PMID 32203186, PMID 32211963, PMID 32234467, PMID 32257537, PMID 32278362, PMID 32283152, PMID 32360286, PMID 32396163, PMID 32653469, PMID 33028396, PMID 36389766, PMID 37546740
2014 (1), 2015 (1), R33AT009991 (1)